Driving Launch Success: Best Practices for Emerging Pharma and Biotechs in the Digital Era

About two-thirds of new drugs fail to meet sales expectations in the first year on the market and many continue to underperform three years post-launch, costing the industry hundreds of millions of dollars in lost revenue.

Before an initial commercial launch, it’s critical for emerging pharma and biotech companies to implement a data-driven well-defined launch strategy years in advance in order to reach their goals.

Read the whitepaper to learn from the experiences of 100+ launches and get started on your path to launch success. You will learn:

  • How a well-structured 30-month foundational roadmap with detailed steps helps align sales, marketing, and medical teams
  • Four operational requirements to prepare go-to-market programs that foster agile, efficient, and intelligent customer engagement
  • How Medac Pharma achieved commercial launch success in just four months, allowing them to reach HCPs efficiently and compliantly


Share content on email